Shares of Regeneron Pharmaceuticals Inc. /zigman2/quotes/203149337/composite REGN +0.84% inched 0.06% higher to $660.86 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index /zigman2/quotes/210599714/realtime SPX +3.06% rising 2.99% to 4,300.17 and the Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +2.68% rising 2.81% to 34,061.06. This was the stock's second consecutive day of gains. Regeneron Pharmaceuticals Inc. closed $86.56 below its 52-week high ($747.42), which the company reached on April 8th.
The stock underperformed when compared to some of its competitors Wednesday, as Johnson & Johnson /zigman2/quotes/201724570/composite JNJ +1.46% rose 1.07% to $180.20, Novartis AG ADR /zigman2/quotes/203243705/composite NVS +3.63% rose 0.90% to $88.27, and Amgen Inc. /zigman2/quotes/209157011/composite AMGN +0.94% rose 1.68% to $236.10. Trading volume (993,860) eclipsed its 50-day average volume of 638,469.